Mumbai (Maharashtra) [India], May 24 (ANI): Equity benchmark indices were flat in volatile trade during early hours on Monday with pharma scrips gaining some ground.
New Delhi [India], May 21 (ANI): Morepen Laboratories said on Friday it has approved an incoming investment of Rs 433 crore to Corinth Investment Holdings AG of Switzerland.
New Delhi [India], May 21 (ANI/BusinessWire India): With the second wave of the Covid pandemic gripping rural India in an unprecedented crisis, the country's leading agriculture company Syngenta India has stepped in to provide support to help farmers cope with healthcare challenges.
New Delhi [India], May 20 (ANI): At least nine people have become new billionaires since the beginning of Covid pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on Covid vaccines are making, the People's Vaccine Alliance said on Thursday ahead of a G20 le
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
Mumbai (Maharashtra) [India], May 19 (ANI): GlaxoSmithKline (GSK) Pharmaceuticals clocked 6 per cent growth in revenue for the January to March quarter at Rs 807 crore as compared to the same period of the previous fiscal.
New Delhi [India], May 19 (ANI): Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.
New Delhi [India], May 19 (ANI): US pharmaceutical giant Johnson and Johnson has joined hands with Biological E Limited (Telangana-based pharma company) for the manufacturing of the COVID-19 vaccine, as per an official statement on Tuesday.
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
New Delhi [India], May 17 (ANI): With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being produced